Empagliflozin in Acute Heart Failure

Clinical trial NCT05305495 · COMPLETED

Trial details

NCT number: NCT05305495
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Heart Failure Chronic Kidney Diseases

Start date: 2022-12-22
Primary completion: 2026-02-15
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.